EN DE

RELX PLC (REL) Fair Value & Analysis

Industrials · GB · Market cap 41.9B GBX

RP RELX PLC REL · LSE
Price£24.17
Fair Value£23.64
Upside-2.2%
Quality67/100
Watch RELX PLC for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Highly profitable · 21.5% net margin
High debt · generates free cash flow
2.84% dividend yield
Mixed vs. peers (8/15)
Wide moat 88/100
Evidence: High Range £15.21 – £30.58 Share as image

Fair value as of: Jul 11, 2026

From 26 valuation models · updated 27 days ago

Fair value updated Jul 11, 2026, revised from £23.47 to £23.64 (+0.7%) since Jun 24, 2026. Share price +5.8% over the past month.

A solid business, currently priced close to our fair value.

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • A fairly wide model range (£15.21 to £30.58) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

£37.44 £15.24 Fair Value £23.64 May 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 11, 2026.

How to read this chart

60‑month range £15.24 – £37.44 · fair‑value band £15.21 – £30.58 · the £24.17 price screens above the £23.64 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 11, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

RELX PLC (REL) currently trades at £24.17, while our model-based Fair Value estimate is £23.64, implying the stock looks roughly 2.2% fairly valued today. We read business quality at 67/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, RELX PLC generated revenue of £9.6B at a net margin of 21.5%. Revenue grew 1.2% year over year. It earns a return on equity of 70.5%. Net debt stands at £7.2B. Fundamentals as of Jul 11, 2026

Our scenario range runs from £15.21 (bear case) to £30.58 (bull case); at £24.17, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Industrials peers we cover trades at -35% fair-value upside, at -2%, REL screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Growth DCF £15.17 £23.17 £34.32 80
Residual Income £5.90 £8.25 £92.42 76
Rev-Margin DCF £9.06 £14.70 £21.01 74
All 26 models by family
DCF Models
FCF DCF £14.74 £23.54 £36.46 38
Owner Earnings £14.37 £22.98 £35.65 31
5Y Revenue Exit £9.06 £14.48 £21.10 39
5Y EBITDA Exit £15.04 £25.35 £37.03 41
5Y P/E Exit £13.28 £22.14 £31.12 38
10Y Revenue Exit £10.71 £16.03 £22.62 36
10Y EBITDA Exit £14.76 £23.46 £34.47 37
10Y P/E Exit £13.65 £21.27 £30.07 35
Earnings-Based
Graham-Dodd £8.03 £21.51 £28.15 54
Lynch FV £4.19 £5.98 £7.78 50
PEG = 1.0 £4.19 £5.98 £7.78 46
EPV £9.44 £11.53 £13.37 59
Dividend Discount
Gordon GGM £6.20 £12.89 £20.45 70
DDM Multi-Stage £6.20 £9.63 £13.29 61
Multiples
P/E Multiple £17.71 £23.61 £29.51 63
P/S Multiple £10.28 £13.70 £17.13 58
P/B Multiple £3.04 £4.06 £5.07 55
EV/EBIT £19.88 £27.55 £35.22 53
EV/EBITDA £17.67 £24.61 £31.55 54
EV/Revenue £6.45 £10.56 £14.67 43
Asset-Based
NCAV (Graham) £0.6800 £0.9100 £1.35 50
Growth DCF
Growth DCF £15.17 £23.17 £34.32 80
Rev-Margin DCF £9.06 £14.70 £21.01 74
Economic Profit
Residual Income £5.90 £8.25 £92.42 76
ROIC Compounder £10.08 £13.12 £16.39 72
Growth Earnings
Growth-Adj P/E £14.00 £20.00 £26.00 68

Widest divergence: DCF Models (£22.14) versus Asset-Based (£0.9100). Highest evidence: Growth DCF (80).

Key figures & financial health

Revenue (TTM) 9.6B GBX
Revenue growth (YoY) +1.2%
Net margin 21.5%
Return on equity 70.5%
Free cash flow 2.9B GBX FY2025
P/E ratio 22.8
More key figures
Operating margin 31.4%
EPS (TTM) £1.12
Dividend yield 2.7%
EPS growth (YoY) +17.0%
Net debt 7.2B GBX FY2025

Figures from reported company fundamentals · as of Jul 11, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 67/100

Of which business quality 73 · Market factors (momentum, volatility) 40

Profitability 78
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 90
Earnings quality: real cash, not paper profit
Fin. Strength 36
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 77
Calm price path (market factor)
Momentum 30
Price trend over the last 3–12 months (market factor)
52W Momentum 16
Distance to the 52-week high (market factor)
Net Issuance 98
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions.

Full company description

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk, as well as a portfolio of commercial healthcare products. Its Scientific, Technical & Medical segment provides scientific and medical information and data sets for science and healthcare. The Legal segment provides legal, regulatory, and business information and analytics. Its Exhibitions segment combines digital tools and data to help customers connect in-person and online, discover new markets, source products, generate leads, and transact. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

RELX PLC reported revenue of £9.6B in FY2025 versus £7.2B in FY2021, a compound +7.3%/yr. Reported net income was £2.1B in FY2025, compounding +8.8%/yr from FY2021.

Growth Quality 82/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
£9.6B
Latest YoY
+1.7%
Avg. growth/yr (3Y)
+3.9%
Avg. growth/yr (5Y)
+6.2%
Avg. growth/yr (39Y)
+4.2%
Revenue +7.3%/yr
FY21 £7.2B
FY22 £8.6B
FY23 £9.2B
FY24 £9.4B
FY25 £9.6B
Net income +8.8%/yr
FY21 £1.5B
FY22 £1.6B
FY23 £1.8B
FY24 £1.9B
FY25 £2.1B

Watch REL: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "RELX PLC Fair Value". https://www.fairvalue-calculator.com/stock/REL

Earlier news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Specialty Business Services · 255 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 67 · Top 25%
Fair Value upside −2% · Above median
Return on equity (TTM) 71% · Top 25%
Return on assets 12% · Top 25%
Net margin (TTM) 22% · Top 25%
Operating margin (TTM) 31% · Top 25%
Revenue growth 1% · Below median
Dividend yield (TTM) 2.8% · Above median
Debt / equity 2.38× · Higher than 75% of peers

Valuation Multiples vs Specialty Business Services median · lower = cheaper

P/E (TTM) 21.4× · Pricier than median
P/B 23.83× · Pricier than 75% of peers
P/S (TTM) 5.88× · Pricier than 75% of peers
P/FCF 19.7× · Pricier than 75% of peers
EV/EBITDA 19.3× · Pricier than 75% of peers
PEG 1.29× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 30 · sector 28
FUTURE 6 · sector 25
PAST 100 · sector 33
HEALTH 0 · sector 92
DIVIDEND 57 · sector 53

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate (as of Jul 11, 2026).

Stock Price Fair Value vs Fair Value
Cintas Corporation CTAS $206.25 $95.30 -54%
Thomson Reuters Corporation TRI C$133.87 C$70.40 -47%
Copart, Inc CPRT $27.61 $28.59 +4%
Global Payments Inc GPN $80.49 $69.67 -13%
RB Global, Inc RBA C$156.43 C$49.14 -69%
Brambles Limited BXB A$18.79 A$12.28 -35%
UL Solutions Inc ULS $87.76 $33.62 -62%
Wolters Kluwer N.V WKL €62.56 €103.99 +66%
Aramark ARMK $56.74 $13.73 -76%
Rentokil Initial plc RTO $30.41 $19.63 -35%

Compare RELX PLC with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is RELX PLC (REL) overvalued or undervalued?
As of Jul 11, 2026, our model estimates a fair value of £23.64 versus a price of £24.17, about −2% (fairly valued).
What is the fair value of REL?
Our model-based fair value for RELX PLC is £23.64 (as of Jul 11, 2026), built from audited fundamentals. The current price is £24.17.
What is the quality score of REL?
RELX PLC has a Quality Score of 67/100. It combines two groups: business quality (profitability, growth, cash flow, balance-sheet strength) and market factors (price momentum, distance to the 52-week high, volatility). Both subtotals are shown separately in the detail view.
What is the revenue of RELX PLC (REL)?
RELX PLC reported trailing-twelve-month revenue of about £9.6B (latest available figure, as of Jul 11, 2026).
What is the net profit margin of REL?
The net profit margin of RELX PLC is about 21.5%, meaning it keeps roughly 21.5% of revenue as net income. Based on the latest reported figures.
Does RELX PLC pay a dividend?
RELX PLC currently shows a dividend yield of about 2.65% relative to its recent price (as of Jul 11, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track RELX PLC and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.